AU2002305720A1 - Piperazine pentanamide hiv protease inhibitors - Google Patents

Piperazine pentanamide hiv protease inhibitors

Info

Publication number: AU2002305720A1
Authority: AU; Australia
Prior art keywords: pentanamide; piperazine; protease inhibitors; hiv protease; hiv
Prior art date: 2001-05-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002305720A

Inventor

Joann M. Bohn

Jiang Chang

Yuan Cheng

Ronald M. Kim

Zhijian Lu

Subharekha Raghavan

Thomas Rano

Dong-Ming Shen

Min Shu

James R. Tata

Fengqi Zhang

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

HUENING TRACY T

Merck and Co Inc

Original Assignee

Merck and Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-30

Filing date

2002-05-24

Publication date

2002-12-09

2002-05-24 Application filed by Merck and Co Inc filed Critical Merck and Co Inc

2002-12-09 Publication of AU2002305720A1 publication Critical patent/AU2002305720A1/en

Status Abandoned legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

AU2002305720A 2001-05-30 2002-05-24 Piperazine pentanamide hiv protease inhibitors Abandoned AU2002305720A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US29437001P	2001-05-30	2001-05-30
US60/294,370		2001-05-30
PCT/US2002/016739 WO2002096359A2 (en)	2001-05-30	2002-05-24	Piperazine pentanamide hiv protease inhibitors

Publications (1)

Publication Number	Publication Date
AU2002305720A1 true AU2002305720A1 (en)	2002-12-09

Family

ID=23133114

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002305720A Abandoned AU2002305720A1 (en)	2001-05-30	2002-05-24	Piperazine pentanamide hiv protease inhibitors

Country Status (2)

Country	Link
AU (1)	AU2002305720A1 (en)
WO (1)	WO2002096359A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6649761B2 (en) *	2001-05-30	2003-11-18	Merck & Co., Inc.	Process for preparing piperazinepentaneamide HIV protease inhibitors
CA2532026C (en)	2003-08-20	2012-04-17	Eli Lilly And Company	Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
US20070293423A1 (en)	2003-08-20	2007-12-20	Eli Lilly And Company	Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60036961T2 (en) *	1999-11-24	2008-08-28	Merck & Co., Inc.	GAMMA-HYDROXY-2- (FLUORALKYLAMINOCARBONYL) -1-PIPERAZINE PENTANAMIDE AS AN HIV PROTEASE INHIBITOR

2002
- 2002-05-24 WO PCT/US2002/016739 patent/WO2002096359A2/en not_active Application Discontinuation
- 2002-05-24 AU AU2002305720A patent/AU2002305720A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2002096359A2 (en)	2002-12-05
WO2002096359A3 (en)	2003-03-13

Similar Documents

Publication	Publication Date	Title
GB0125445D0 (en)	2001-12-12	Protease Inhibitors
AU2002305926A1 (en)	2002-10-08	Cysteine protease inhibitors
AU2003248872A1 (en)	2004-01-23	Hiv integrase inhibitors
AU2003213776A1 (en)	2003-09-29	Carbamates as hiv protease inhibitors
AU6007200A (en)	2001-02-19	Cysteine protease inhibitors
AU2001247589A1 (en)	2001-10-03	Non-amidine containing protease inhibitors
AU2003257284A1 (en)	2004-07-14	Aromatic derivatives as hiv aspartyl protease inhibitors
IL158093A0 (en)	2004-03-28	Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
AU2003269984A1 (en)	2004-03-11	Protease inhibitors
AU1588901A (en)	2001-06-06	Protease inhibitors
AU1474801A (en)	2001-06-06	Protease inhibitors
AU2002342682A1 (en)	2002-11-25	Protease inhibitors
AU1474701A (en)	2001-06-06	Protease inhibitors
AU4066900A (en)	2000-10-16	Protease inhibitors
AU3888200A (en)	2000-10-04	Protease inhibitors
AU1474601A (en)	2001-06-06	Protease inhibitors
AU2002305720A1 (en)	2002-12-09	Piperazine pentanamide hiv protease inhibitors
AU2003263738A1 (en)	2003-12-02	Protease inhibitors
GB0123467D0 (en)	2001-11-21	Carbocyclic HIV Protease inhibitors
AU2001280634A1 (en)	2002-02-13	Salt forms of an hiv protease inhibitor
AU2003287325A1 (en)	2004-06-03	N-cycloalkylglycines as hiv protease inhibitors
AU2002255613A1 (en)	2002-09-12	Piperazine derivatives as metalloprotease inhibitors
AU2002363791A1 (en)	2003-05-26	Protease enzyme inhibitors
GB0028483D0 (en)	2001-01-10	Hydroxyethylamine HIV protease inhibitors
AU2003304496A1 (en)	2005-04-27	Protease inhibitors

Legal Events

Date	Code	Title	Description
2004-03-11	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase